NYSE$NLOP
Net Lease Office Properties · Q3 2025 earnings
Q3 2025 earnings · · After market close · Investor relations
Briefing
NLOP reported Q3 2025, revenue of $29.8M, a net loss of $64.2M.
For Q3 2025, NLOP reported revenue of $29.8M, a net loss of $64.2M. Management discusses operating trends, liquidity, and strategic priorities as disclosed in the quarterly filing.
- Revenue $29.8M.
- Net loss $64.2M.
- NLOP updated clinical, capital, or portfolio priorities in the filing.
Headline financials
Revenue & EPS history
Net Lease Office Properties · Revenue · Quarterly
$29.8M
Forward guidance
Management discusses NLOP's outlook, capital deployment, and key risks as disclosed in the earnings materials and periodic report.
Tailwinds
- NLOP cited progress on strategic priorities in the quarterly filing.
- Liquidity and balance sheet support continued operations and investment.
Headwinds
- GAAP profitability remained under pressure in the reported quarter.
- Macro, competitive, and regulatory factors may affect near-term results.
- R&D, credit, or project timing can create quarter-to-quarter volatility.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 11 quarterly earnings reports · overlaid with Q3 2025
+0.6%
Avg return
Earnings day
-0.6%
Avg return
5 days after
+0.4%
Avg return
30 days after
42%
5 / 12 earnings
Positive
+6.2%
Q3 2023
Best reaction
-3.3%
Q4 2025
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +1.1% | -9.0% | -8.2% | |
| Q4 2025 | -3.3% | +2.4% | -10.8% | |
| Q3 2025 | +0.0% | +0.3% | -15.3% | |
| Q1 2025 | +1.3% | +0.3% | +4.6% | |
| Q4 2024 | -2.1% | -4.9% | -11.4% | |
| Q3 2024 | +3.0% | +4.6% | +5.4% | |
| Q2 2024 | +6.1% | +4.1% | +3.6% | |
| Q1 2023 | -0.7% | -1.7% | -6.3% | |
| Q1 2024 | -1.9% | -2.3% | -3.9% | |
| Q2 2023 | -0.0% | +2.6% | -2.7% | |
| Q4 2023 | -1.7% | -4.2% | +36.7% | |
| Q3 2023 | +6.2% | +0.2% | +13.6% | |
| Q4 2022 | — | — | — | |
| Q3 2022 | — | — | — | |
| Q2 2022 | — | — | — | |
| Q1 2022 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro